Search
Search Results
##search.searchResults.foundPlural##
-
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
934PDF: 567HTML: 2187Cover Letter: 189 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1149PDF: 909HTML: 286 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3041PDF: 871HTML: 7162Kost Fig1: 178Kost Fig 2: 176Kost Fig3: 173Kost Fig 4: 186Kost Fig5: 183Kost fig 6: 171 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1959PDF: 742HTML: 694 -
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2844PDF: 1434HTML: 3045Cover Letter: 205 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1087PDF: 539HTML: 1689Figures: 165Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3664PDF: 1281HTML: 725Figure 2: 449Figure 1: 3114 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6918PDF: 3907HTML: 24875 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3250PDF: 1525HTML: 417 -
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1575PDF: 775HTML: 812tile page: 160Table 1: 161







